Czechia, May 29 -- Czechia based Takeda Pharmaceuticals Czech Republic s.r.o. has secured contract from Institut klinicke a experimentalni mediciny for Immunosuppressive agents - Selective Immunosuppressants - Vedolizumab VII . The value of the contract is worth 10055088200 CZK .
Published by HT Digital Content Services with permission from Pivotal Sources....